In a closed-door meeting at a Manhattan mansion, executives outlined changes to controversial software that was implicated in two crashes.Aerospace & Defenseread more
Current and former Tesla employees working in the company's open-air "tent" factory say they felt pressure to take shortcuts to hit aggressive Model 3 production goals,...Technologyread more
Amazon workers in Minnesota and Germany are striking as Prime Day kicks off, in a stand against working conditions and wage practices. The action in Minnesota represents the...Retailread more
Treasury Secretary Steven Mnuchin is raising red flags ahead of Facebook's proposed cryptocurrency launch.Marketsread more
Epstein is accused of sexually exploiting dozens of underage girls from 2002 through 2005 at his New York and Florida residences. He is a former friend of Presidents Donald...Politicsread more
When you think of Prime Day, you might be thinking about deals on Instant Pots and Amazon Echo devices — not half-off dresses and designer heels. But the market for apparel...Retailread more
David Marcus, the head of Facebook's digital currency project, said the company expects Libra will drive more advertising revenue for the company.Technologyread more
Some White House officials expect the Cabinet secretary, who has known the president for years, to depart as soon as this summer.Politicsread more
"The important thing is that you shouldn't try to hit homeruns this week, because you're much more likely to end up striking out," Jim Cramer says.Mad Money with Jim Cramerread more
Reps. Ilhan Omar, Ayanna Pressley, Alexandria Ocasio-Cortez and Rashida Tlaib said Trump challenged them personally because he was not able to defeat them on the policy level.Politicsread more
A financial disclosure made by lawyers for Jeffrey Epstein, a former friend of presidents Donald Trump and Bill Clinton, reveals he has nearly $560 million in assets.Politicsread more
But the consumers who order the tests often face months-long waits to get an appointment with a genetics expert who can explain the results. That's because there are fewer than 5,000 genetic counselors in the United States, which falls far short of the demand. Given the lack of training programs, genetic experts predict that the supply won't reach an equilibrium until 2024.
So a group of health veterans is forming a new technology startup called Genome Medical to train genetic experts, and provide $149 video consultations to both doctors and patients.
The company was founded by Lisa Alderson and Randy Scott, former executives from Invitae, a company that is aiming to become the "Amazon for genetics, " and Harvard Medical School geneticist Robert Green.
In an exclusive interview with CNBC, Alderson said the company has raised more than $12 million from Canaan Partners, Illumina Ventures, and others.
Recent studies have found that genetic testing costs patients and their insurers between $300 million and $600 million each year in the U.S. alone. The market for precision medicine, which involves a boost in human genetic testing, is expected to reach $87.79 billion by 2023.
Alderson said genetic-testing companies are increasingly willing to pay for access to experts, who can help patients understand their results. The initial areas of focus for the company include reproductive health, cancer and preventative medicine.
Illumina, maker of DNA sequencing machines, is partnering up with Genome Medical for its program, known as Understand Your Genome, which offers whole genome sequencing to professionals for $2,900.
Illumina's vice president of applied genomics Dawn Barry said that Genome Medical's experts will help consumers determine if they need the test at all and what to expect. Barry described the technology as a "critical connection."
Federal regulators have expressed concern about companies that offer genetic information to consumers, without expert oversight. The U.S. Food and Drug Administration made that clear in November of 2013 when it ordered direct-to-consumer testing company 23andMe to stop selling its tests, although the FDA more recently approved 23andMe tests for some specific functions. (23andMe is not a partner of Genome Medical.)
"There will be a tremendous increase and interest in utilizing genetic testing," added Genome Medical's Green. "But everyone agrees that the current medical workforce isn't prepared for that."